Paulus Widjanarko Brotosaputro
Ventas & Marketing en PT PYRIDAM FARMA TBK .
Cargos activos de Paulus Widjanarko Brotosaputro
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PT PYRIDAM FARMA TBK | Ventas & Marketing | 21/05/2019 | - |
PT Holi Pharma
PT Holi Pharma Pharmaceuticals: MajorHealth Technology Part of PT Pyridam Farma Tbk, PT Holi Pharma is a pharmaceutical company based in Cimahi, Indonesia. PT Holi Pharma manufactures pharmaceuticals. PT Holi Pharma was acquired by PT Pyridam Farma Tbk on December 28, 2021 for $7.49 million. | Director/Miembro de la Junta | - | - |
Historial de carrera de Paulus Widjanarko Brotosaputro
Antiguos cargos conocidos de Paulus Widjanarko Brotosaputro.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PT IKAPHARMINDO PUTRAMAS TBK | Corporate Officer/Principal | 01/01/2016 | 01/12/2016 |
PT Meprofarm Pharmaceutical Industries
PT Meprofarm Pharmaceutical Industries Pharmaceuticals: MajorHealth Technology PT Meprofarm Pharmaceutical Industries is a private company based in Bandung, ID. The company's headquarters and factory are located on Jl. The Indonesian company produces high-quality pharmaceutical products and continuously strives for improvement. The company has a mature and efficient corporate culture that values honesty, communication, reliability, and optimism. In addition to their business operations, the company is also committed to social responsibility through their CSR programs, which focus on health, education, and community empowerment. The company's product line includes antacids, antireflux agents, antiulcerants, drugs for musculo-skeletal system, nutraceutical products, and adjuvant therapy. Soekarno Hatta. | Ventas & Marketing | 01/01/2014 | 01/12/2015 |
PT Combiphar
PT Combiphar Pharmaceuticals: MajorHealth Technology PT Combiphar is a pharmaceutical company based in Jakarta Selatan, Indonesia. and has subsidiaries in Indonesia. Combiphar has since grown and now markets over 80 affordable prescription and over-the-counter drugs, including Obh Combi and Insto. The Indonesian company has developed more than 100 products through its research and development center and under license from partners and principals. Obat batuk Obh Combi is one of its most well-known products. The private company was founded in 1971 from a cottage industry in Bandung, which produced antibiotic drugs, analgesic, and legendary black cough medicine. Michael Wanandi has been the CEO of the company since 2011. | Ventas & Marketing | 01/03/2007 | 01/12/2013 |
Pt Yarindo Farmatama | Ventas & Marketing | 01/07/2006 | 01/02/2007 |
PT Prima Hexal | Oficial de Cumplimiento | 01/08/2005 | 01/06/2006 |
PT Combiphar
PT Combiphar Pharmaceuticals: MajorHealth Technology PT Combiphar is a pharmaceutical company based in Jakarta Selatan, Indonesia. and has subsidiaries in Indonesia. Combiphar has since grown and now markets over 80 affordable prescription and over-the-counter drugs, including Obh Combi and Insto. The Indonesian company has developed more than 100 products through its research and development center and under license from partners and principals. Obat batuk Obh Combi is one of its most well-known products. The private company was founded in 1971 from a cottage industry in Bandung, which produced antibiotic drugs, analgesic, and legendary black cough medicine. Michael Wanandi has been the CEO of the company since 2011. | Ventas & Marketing | 01/04/2004 | 01/06/2005 |
Pt Novartis Biochemie | Corporate Officer/Principal | 01/02/1997 | 01/03/2004 |
Formación de Paulus Widjanarko Brotosaputro.
Universitas Tarumanagara | Undergraduate Degree |
Prasetiya Mulya Business School | Graduate Degree |
Estadísticas
Internacional
Indonesia | 11 |
Operativa
Sales & Marketing | 5 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PT PYRIDAM FARMA TBK | Health Technology |
PT IKAPHARMINDO PUTRAMAS TBK | Health Technology |
Empresas privadas | 6 |
---|---|
PT Combiphar
PT Combiphar Pharmaceuticals: MajorHealth Technology PT Combiphar is a pharmaceutical company based in Jakarta Selatan, Indonesia. and has subsidiaries in Indonesia. Combiphar has since grown and now markets over 80 affordable prescription and over-the-counter drugs, including Obh Combi and Insto. The Indonesian company has developed more than 100 products through its research and development center and under license from partners and principals. Obat batuk Obh Combi is one of its most well-known products. The private company was founded in 1971 from a cottage industry in Bandung, which produced antibiotic drugs, analgesic, and legendary black cough medicine. Michael Wanandi has been the CEO of the company since 2011. | Health Technology |
PT Prima Hexal | |
PT Meprofarm Pharmaceutical Industries
PT Meprofarm Pharmaceutical Industries Pharmaceuticals: MajorHealth Technology PT Meprofarm Pharmaceutical Industries is a private company based in Bandung, ID. The company's headquarters and factory are located on Jl. The Indonesian company produces high-quality pharmaceutical products and continuously strives for improvement. The company has a mature and efficient corporate culture that values honesty, communication, reliability, and optimism. In addition to their business operations, the company is also committed to social responsibility through their CSR programs, which focus on health, education, and community empowerment. The company's product line includes antacids, antireflux agents, antiulcerants, drugs for musculo-skeletal system, nutraceutical products, and adjuvant therapy. Soekarno Hatta. | Health Technology |
Pt Novartis Biochemie | |
Pt Yarindo Farmatama | |
PT Holi Pharma
PT Holi Pharma Pharmaceuticals: MajorHealth Technology Part of PT Pyridam Farma Tbk, PT Holi Pharma is a pharmaceutical company based in Cimahi, Indonesia. PT Holi Pharma manufactures pharmaceuticals. PT Holi Pharma was acquired by PT Pyridam Farma Tbk on December 28, 2021 for $7.49 million. | Health Technology |